Adaeze Precious Ekwe
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Adaeze Precious Ekwe has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Alda Saldan
Department of Molecular Medicine, University of Padua, Padua, Italy
1 shared publication Andrea S. Henden
Translational Cancer Immunotherapy Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia; Department of Haematology and Bone Marrow Transplantation, Cancer Care Services, Royal Brisbane and Women's Hospital, Herston, Queensland, Australia; Faculty of Medicine, University of Queensland, St Lucia, Queensland, Australia
1 shared publicationAshleigh Henderson
Department of Haematology and Bone Marrow Transplantation, Cancer Care Services, Royal Brisbane and Women's Hospital, Herston, Queensland, Australia
1 shared publication- Benjamin A. McEnroe
Institute for Experimental Oncology, University of Bonn, University Hospital Bonn, Bonn, Germany
1 shared publication - Ceara C McGowan
Queensland University of Technology
1 shared publication - Cheryl J. Hutchins
Department of Haematology and Bone Marrow Transplantation, Cancer Care Services, Royal Brisbane and Women's Hospital, Herston, Queensland, Australia
1 shared publication
Latest Publications
- Open Access
- 8 December 2024
- Published by Taylor & Francis in Clinical and Experimental Optometry
- Vol. 108 (5) , 544-555
Current and emerging strategies for the manufacture, implantation, and clinical management of corneal tissue allografts
Approximately 40,000 Australians have received a donor corneal tissue transplant over the last 40 years, with the primary indications being keratoconus, Fuchs' endothelial dystrophy, bullous keratopathy, and failure of a prior corneal transplant. Although corneal cross-linking and rigid contact lenses have emerged as alternative strategies for the management of keratoconus, the demand for donor corneas is increasing in-line with the ageing population in Australia. Moreover, owing to the lack of tissue banking resources in less-developed countries, the global demand for donor corneas exceeds supply by 70-fold. These supply issues, combined with evolving tissue banking and surgical techniques, have led to the emergence of new strategies for the storage, processing and implantation of corneal cells and tissues. Organ culture techniques have been developed that support the storage of donor corneas for up to 30 days, facilitating improvements in tissue supply and surgery scheduling. Bespoke surgical methods have been developed that are tailored to the requirements of specific conditions, allowing reductions in both the volume of tissue required to be transplanted and the size of the necessary surgical incision. Further efficiencies and improvements in patient care may be achieved via exploitation of cell culture technologies as exemplified through use of cultured corneal epithelial cells for the treatment of limbal stem cell deficiency. Promising progress has also been made in developing a cultured corneal endothelial cell therapy for patients with corneal endothelial dysfunction. These evolving strategies are discussed with respect to their potential impact on the clinical presentation and management of patients who have received an implant of donor corneal tissue or cells.
- 8 December 2024
- Published by Taylor & Francis in Clinical and Experimental Optometry
- Vol. 108 (5) , 544-555
Open AccessCurrent and emerging strategies for the manufacture, implantation, and clinical management of corneal tissue allografts
Approximately 40,000 Australians have received a donor corneal tissue transplant over the last 40 years, with the primary indications being keratoconus, Fuchs' endothelial dystrophy, bullous keratopathy, and failure of a prior corneal transplant. Although corneal cross-linking and rigid contact lenses have emerged as alternative strategies for the management of keratoconus, the demand for donor corneas is increasing in-line with the ageing population in Australia. Moreover, owing to the lack of tissue banking resources in less-developed countries, the global demand for donor corneas exceeds supply by 70-fold. These supply issues, combined with evolving tissue banking and surgical techniques, have led to the emergence of new strategies for the storage, processing and implantation of corneal cells and tissues. Organ culture techniques have been developed that support the storage of donor corneas for up to 30 days, facilitating improvements in tissue supply and surgery scheduling. Bespoke surgical methods have been developed that are tailored to the requirements of specific conditions, allowing reductions in both the volume of tissue required to be transplanted and the size of the necessary surgical incision. Further efficiencies and improvements in patient care may be achieved via exploitation of cell culture technologies as exemplified through use of cultured corneal epithelial cells for the treatment of limbal stem cell deficiency. Promising progress has also been made in developing a cultured corneal endothelial cell therapy for patients with corneal endothelial dysfunction. These evolving strategies are discussed with respect to their potential impact on the clinical presentation and management of patients who have received an implant of donor corneal tissue or cells.
- 5 March 2024
- Published by Elsevier in Cytotherapy
- Vol. 26 (7) , 719-728
Clinical grade multiparametric cell sorting and gene-marking of regulatory T cells
- 5 March 2024
- Published by Elsevier in Cytotherapy
- Vol. 26 (7) , 719-728
Clinical grade multiparametric cell sorting and gene-marking of regulatory T cells